|
|
Type of Company:
Type:
|
Company
|
Ownership: |
Publicly Traded |
Company Size: |
20 Employees In BC (20 Total)
20 In BC (20 Total)
|
Year Founded: |
1967 |
Sector: |
Biotech/Life Sciences
Biotech/Life Sciences
|
Region: |
Lower Mainland / South Coast
Lower Mainland
|
Tags: |
replicel, biotech, hair, hair loss, implantation
|
Profile Views: |
1,006 Company Profile Views |
|
|
|
RepliCel Life Sciences Inc. is developing a scientific technology that has the potential to become the world's first, minimally invasive, permanent solution for hair loss in men and women.
Using autologous cell implantation technology, dermal sheath cup cells are taken from a patient's own healthy hair follicles and are replicated into the millions over a three month period. These cells are reintroduced into areas of hair loss and the anticipated result is the development of new hair follicles. The procedure has been in development over the past nine years by the company's research scientists and medical experts, and is currently undergoing phase I/IIa clinical trials in Europe. |
|
|
Date |
Type |
Amount |
Investors |
Date |
Type |
Amount |
Investors |
|
|
|
Want More RepliCel Life Sciences Inc. News? 1 2 3
|
Next »
|
|
|
|
|
|
|
Apr 26, 2019
|
RepliCel Secures Several New Patents for its Regenerative Medicine Technologies
|
|
Mar 26, 2019
|
RepliCel Says Licensee YOFOTO (China) Health Building Momentum in China with Facility and Team
|
|
Mar 22, 2019
|
RepliCel Reignites its First-in-Japan Strategy
|
|
Mar 12, 2019
|
RepliCel CEO Provides 2019 Shareholder Update
|
|
Dec 4, 2018
|
RepliCel Life Sciences Appoints Head of Clinical and Regulatory Affairs
|
|
Oct 30, 2018
|
RepliCel Life Sciences Appoints New Chief Financial Officer
|
|
Oct 24, 2018
|
RepliCel Announces Federal Grant Funding for Collaboration with the University of Victoria, Canada
|
|
Oct 16, 2018
|
RepliCel Life Sciences Completes $5 Million Financing with YOFOTO (China) Health
|
|
Oct 5, 2018
|
RepliCel Life Sciences and YOFOTO (China) Health Obtain All Approvals Needed to Complete $5M Investment
|
|
Jul 24, 2018
|
RepliCel Life Sciences Announces $5M Investment and Signed Licensing and Co-Development Deal for Greater China
|
|
|
1 - 10 of 26 results
|
|
 |
|
|
|
Share This Company Profile |
|
|
|
|
|
|
Disclaimer: Company Profiles in the Tech Directory on T-Net are created, edited and maintained primarily by employees within individual companies, and are subject to continual change without notice and possible errors and/or omissions. Information within the pages of this Tech Directory is of a general nature intended only for informational purposes, and such information should not be relied upon. T-Net does not warrant or guarantee the quality, accuracy or completeness of such information and expressly disclaims liability for any loss, inconvenience or damages (including special, indirect or consequential damages) caused as a result of any errors in, or omissions from, such information. If you see an error, please let us know. Copyright T-Net. All rights reserved.
|
|
News
Events
Tech Careers
Directory
Tech Stocks
T-Net 100
Members
Feedback
About T-Net
Employers
Post Job Listings
Advertise
